Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemiareperfusion injury in a rat kidney transplant model

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1813-1820

  Martinez Palli, Graciela ^a,b   Hirose, Ryutaro ^a   Liu, Tao ^a   Xu, Fengyun ^a   Dang, Kim ^a,c   Feiner, John ^a   Serkova, Natalie J ^d   Niemann, Claus U ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

cyclosporine; everolimus; ischaemia reperfusion injury; metabolomics; rat kidney transplantation

Indexed keywords

3 NITROTYROSINE; CASPASE 3; CYCLOSPORIN A; EVEROLIMUS; HEAT SHOCK PROTEIN 70; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; REPERFUSION INJURY;

ANIMALS; CYCLOSPORINE; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SIROLIMUS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 79958152331     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq646     Document Type: Article

References (27)

1. Delbridge MS, Shrestha BM, Raftery ATet al. Reduction of ischemiareperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine. Transplantation 2007; 84: 187-195. (Pubitemid 47205752)
2. Niemann CU, Saeed M, Akbari H et al. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. J Pharmacol Exp Ther 2002; 302: 1123-1128. (Pubitemid 34920234)
3. Piot C, Croisille P, Staat P et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008; 359: 473-481.
4. Yang CW, Ahn HJ, Han HJ et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/ reperfusion injury in rat kidney. Transplantation 2001; 72: 1753-1759. (Pubitemid 33144228)
5. Andoh TF, Burdmann EA, Bennett WM. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Semin Nephrol 1997; 17: 34-45.
6. Bobadilla NA, Gamba G. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am J Physiol Renal Physiol 2007; 293: F2-F9. (Pubitemid 47345003)
7. Kahan BD. Immunosuppressive therapy. Curr Opin Immunol 1992; 4: 553-560.
8. Kahan BD, Kramer WG. Median effect analysis of efficacy versus adverse effects of immunosuppressants. Clin Pharmacol Ther 2001; 70: 74-81. (Pubitemid 32678805)
9. Serkova N, Christians U. Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides. Curr Opin Investig Drugs 2003; 4: 1287-1296. (Pubitemid 38100573)
10. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004; 4: 97-107. (Pubitemid 38584972)
11. Nashan B, Curtis J, Ponticelli C et al. Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study. Transplantation 2004; 78: 1332-1340. (Pubitemid 39507973)
12. SinghD, ChanderV, Chopra K. Cyclosporine protects against ischemia/ reperfusion injury in rat kidneys. Toxicology 2005; 207: 339-347. (Pubitemid 40138931)
13. Nakai A, Shibazaki Y, Taniuchi Y et al. Role of mitochondrial permeability transition in fetal brain damage in rats. Pediatr Neurol 2004; 30: 247-253. (Pubitemid 38490435)
14. Serkova N, Donohoe P, Gottschalk S et al. Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia. J Cereb Blood Flow Metab 2002; 22: 342-352. (Pubitemid 34203062)
15. Delbridge MS, Shrestha BM, Raftery AT et al. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury. Transplant Proc 2007; 39: 2992-2996. (Pubitemid 350251451)
16. Goncalves GM, Cenedeze MA, Feitoza CQ et al. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury. Transplant Proc 2007; 39: 417-420. (Pubitemid 46386247)
17. Goncalves GM, Cenedeze MA, Feitoza CQ et al. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int 2006; 70: 1742-1749. (Pubitemid 44684805)
18. Inman SR, Davis NA, Olson KM et al. Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury. Urology 2003; 62: 750-754. (Pubitemid 37205027)
19. Horton J. Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology 2003; 189: 75-88. (Pubitemid 36725024)
20. Niemann CU, Serkova NJ. Biochemical mechanisms of nephrotoxicity: application for metabolomics. Expert Opin Drug Metab Toxicol 2007; 3: 527-544. (Pubitemid 351324962)
21. Fuller TF, Rose F, Singleton KD et al. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. J Surg Res 2007; 140: 77-83. (Pubitemid 46669543)
22. Fuller TF, Serkova N, Niemann CU et al. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J Urol 2004; 171: 1296-1300. (Pubitemid 38327598)
23. Serkova N, Fuller TF, Klawitter J et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005; 67: 1142-1151. (Pubitemid 41623341)
24. Fuller TF, Freise CE, Serkova N et al. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003; 76: 1594-1599. (Pubitemid 37549833)
25. Serkova N, Klawitter J, Niemann CU. Organ-specific response to inhibition of mitochondrial metabolism by cyclosporine in the rat. Transpl Int 2003; 16: 748-755. (Pubitemid 37408597)
26. Serkova NJ, Zhang Y, Coatney JL et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 2007; 83: 517-521. (Pubitemid 46667858)
27. Shihab FS, Bennett WM, Andoh TF. Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Transplantation 2009; 87: 326-329